Search Ontology: 
        
        ChEBI
            prostaglandin E2
- Term ID
 - CHEBI:15551
 - Synonyms
 - 
    
        
        
- (15S)-prostaglandin E2
 - (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
 - (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
 - (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
 - (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
 - (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
 - (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
 - Cervidil
 - Cerviprime
 - Cerviprost
 - Dinoproston
 - dinoprostona
 - dinoprostone
 - dinoprostonum
 - Enzaprost E
 - Glandin-E2
 - Minprositin E2
 - Minprostin E2
 - PGE2
 - Prepidil
 - Propess
 - Prostaglandin E2
 - Prostarmon E
 - Prostenone
 - Prostin
 - Prostin E2
 - U 12062
 - U-12,062
 - U-12062
 
 - Definition
 - Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
 - References
 - 
    
        
        
    
    
- Beilstein:2224724
 - CAS:363-24-6
 - DrugBank:DB00917
 - Drug_Central:913
 - FooDB:FDB022498
 - HMDB:HMDB0001220
 - KEGG:C00584
 - KEGG:D00079
 - LINCS:LSM-42919
 - LIPID_MAPS_instance:LMFA03010003
 - PDBeChem:P2E
 - PMID:11279302
 - PMID:12746806
 - PMID:12859290
 - PMID:14499495
 - PMID:14535055
 - PMID:14703707
 - PMID:15542928
 - PMID:15661432
 - PMID:16405508
 - PMID:16787416
 - PMID:16978535
 - PMID:20671299
 - PMID:2403792
 - PMID:24501112
 - PMID:32898608
 - PMID:33271839
 - PMID:33559528
 - PMID:33685091
 - PMID:33715333
 - PMID:33782420
 - PMID:33811074
 - PMID:33958485
 - PMID:34065827
 - PMID:34071686
 - PMID:34102274
 - PMID:6317292
 - PMID:7224729
 - PMID:74611
 - PMID:7836930
 - PMID:9276764
 - Patent:DE2011969
 - Patent:GB851827
 - Patent:NL6505799
 - Patent:US3598858
 - Reaxys:2224724
 - Wikipedia:Prostaglandin_E2
 
 - Ontology
 - ChEBI ( EBI )
 - Resources
 - CTD
 
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from prostaglandin E2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain prostaglandin E2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing prostaglandin E2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting prostaglandin E2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model